Study of inflammation during catheter ablation for atrial fibrillation
Part of Heart & circulation clinical trials.
This study measures changes in inflammation in people with atrial fibrillation (AF) who are getting a catheter ablation procedure. It may help doctors better understand what happens in the body during the procedure and why some patients do better than others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation that is paroxysmal or persistent (not temporary only).
- You are scheduled for an approved catheter ablation procedure for AF.
- Your age is between 18 and 85 years.
- You can clearly agree to take part in the study (give informed consent).
- Before the procedure, testing does not show a clot in the left atrial area (left auricular thrombosis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
This study is a registry that collects information from patients with atrial fibrillation who are having an ablation procedure. It aims to improve care and research by tracking outcomes. You may be able to join if you are scheduled for an ablation, and some participants may be asked to take part in additional optional sub-studies.
This trial studies abnormal electrical signals in the right upper heart chamber and how they relate to atrial fibrillation (AF). It may help improve how doctors target AF treatment during catheter ablation for people who have AF symptoms.
This study follows people after a procedure called catheter ablation to treat atrial fibrillation (an irregular heart rhythm). It aims to learn which factors help predict outcomes, so future care can be better tailored.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study collects information from people with atrial fibrillation who are having a catheter ablation procedure using the TactiFlex catheter. It helps doctors learn more about how well this catheter works in real-life patients.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.